Article
23 Dec 2025
Increasing Medical Marijuana And Cannabidiol Research (Trump EO Tracker)
CONTRIBUTING SINCE APRIL 2000
Akin Gump Strauss Hauer & Feld LLP
Akin is a law firm focused on providing extraordinary client service, a rewarding environment for our diverse workforce and exceptional legal representation irrespective of ability to pay. The deep transactional, litigation, regulatory and policy experience we bring to client engagements helps us craft innovative, effective solutions and strategies.
POPULAR TOPICS
Government, Public Sector
Energy and Natural Resources
Food, Drugs, Healthcare, Life Sciences
International Law
Technology
Akin Gump Strauss Hauer & Feld LLP are most popular:
- within Litigation and Mediation & Arbitration topic(s)
DETAILS
United States
+1 202. 887.4000
Robert S. Strauss Tower 2001 K Street,
Washington, DC
United States
Contact Firm
COMPANY CONTENT
Article
23 Dec 2025
CARB Unveils Draft Rules For SB 253 And SB 261 Ahead Of February Hearing
Article
23 Dec 2025
IPR Estoppel Under § 315(e)(1) Does Not Apply To Ongoing Ex Parte Reexamination
Article
23 Dec 2025
UK Government Confirms Plans To Legislate To Reverse PACCAR And Restore Clarity For Litigation Funding
Article
23 Dec 2025
Ineffective Retroactive Amendment Of Patent Assignment Dooms $20 Million Damages Verdict
Article
23 Dec 2025
Key Takeaways From The 2025 National Security Strategy: What Has Changed And What It Means For Business
Article
22 Dec 2025
ISS And Glass Lewis Publish 2026 Benchmark Proxy Voting Policies
Article
22 Dec 2025
Restricting And Limiting The Entry Of Foreign Nationals To Protect The Security Of The United States (Trump EO Tracker)
Article
22 Dec 2025
New California Regulations Regarding Employer Use Of Automated Decision-Making Technology: Compliance Required By January 1, 2027
Article
22 Dec 2025
California's Assembly Bill 692, Restricting Many So-Called "Stay-or-Pay" Employment Contract Terms, Set To Take Effect January 1, 2026
Article
19 Dec 2025
The Impact Of The ASC 842 Lease Accounting Standards On A Toll Agreement For Stand-Alone BESS
Article
19 Dec 2025
Holiday Sale? Minnesota Reduces PFAS-in-Products Reporting Fees
Article
19 Dec 2025
FDA's TEMPO Pilot Seeks To Expand Access To Chronic Disease Technologies In CMS Collaboration
Article
19 Dec 2025
Delaware District Court Clarifies That Enhanced Damages Are A Form Of Relief, Not A Claim That Can Be Dismissed On A Motion Under Rule 12(b)(6)
Article
18 Dec 2025
President Trump Unveils AI EO Advancing Federal Preemption Of State Laws
Article
18 Dec 2025
Speaking Sustainability - Legal & Regulatory Updates - November 2025
Article
18 Dec 2025
President Trump Unveils AI EO Advancing Federal Preemption Of State Laws
Article
17 Dec 2025
Artificial Intelligence In Clinical Decision-Making: Regulatory Roadmap And Reimbursement Strategies
Article
17 Dec 2025
Cyber Protections Set To Advance In Must-Pass Defense Legislation
Article
17 Dec 2025
Congress Moves Forward With AI Measures In Key Defense Legislation
AWARDS
